These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 31018669)

  • 61. Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review.
    Mastrolia I; Foppiani EM; Murgia A; Candini O; Samarelli AV; Grisendi G; Veronesi E; Horwitz EM; Dominici M
    Stem Cells Transl Med; 2019 Nov; 8(11):1135-1148. PubMed ID: 31313507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular Prospective on Malignant Transformation of Mesenchymal Stem Cells: An Issue in Cell Therapy.
    Kaviani M; Soleimanian S; Keshtkar S; Azarpira N; Asvar Z; Pakbaz S
    Cell Reprogram; 2024 Jun; 26(3):96-106. PubMed ID: 38917438
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy.
    Li J; Wu Z; Zhao L; Liu Y; Su Y; Gong X; Liu F; Zhang L
    Stem Cell Res Ther; 2023 Dec; 14(1):381. PubMed ID: 38124129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modulation of autophagy as new approach in mesenchymal stem cell-based therapy.
    Jakovljevic J; Harrell CR; Fellabaum C; Arsenijevic A; Jovicic N; Volarevic V
    Biomed Pharmacother; 2018 Aug; 104():404-410. PubMed ID: 29787987
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives.
    Pers YM; Ruiz M; Noël D; Jorgensen C
    Osteoarthritis Cartilage; 2015 Nov; 23(11):2027-35. PubMed ID: 26521749
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.
    Reiser J; Zhang XY; Hemenway CS; Mondal D; Pradhan L; La Russa VF
    Expert Opin Biol Ther; 2005 Dec; 5(12):1571-84. PubMed ID: 16318421
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.
    Volarevic V; Nurkovic J; Arsenijevic N; Stojkovic M
    Stem Cells; 2014 Nov; 32(11):2818-23. PubMed ID: 25154380
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects.
    Das M; Mayilsamy K; Mohapatra SS; Mohapatra S
    Rev Neurosci; 2019 Nov; 30(8):839-855. PubMed ID: 31203262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.
    Ding SLS; Kumar S; Mok PL
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.
    Barrachina L; Romero A; Zaragoza P; Rodellar C; Vázquez FJ
    Vet J; 2018 Aug; 238():49-57. PubMed ID: 30103915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo.
    Hu C; Li L
    Stem Cell Res Ther; 2019 Jan; 10(1):13. PubMed ID: 30635065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
    Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
    Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
    Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine.
    Wilson A; Webster A; Genever P
    Regen Med; 2019 Jun; 14(6):595-611. PubMed ID: 31115266
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Secretion, migration and adhesion as key processes in the therapeutic activity of mesenchymal stem cells.
    Kot M; Musiał-Wysocka A; Lasota M; Ulman A; Majka M
    Acta Biochim Pol; 2019 Dec; 66(4):499-507. PubMed ID: 31883363
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
    Rodríguez R; García-Castro J; Trigueros C; García Arranz M; Menéndez P
    Adv Exp Med Biol; 2012; 741():187-205. PubMed ID: 22457111
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Mesenchymal stem cells: immunomodulatory properties and clinical application].
    Golemović M; Skifić M; Cepulić BG
    Lijec Vjesn; 2012; 134(1-2):42-9. PubMed ID: 22519252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine.
    Nowakowski A; Walczak P; Janowski M; Lukomska B
    Stem Cells Dev; 2015 Oct; 24(19):2219-42. PubMed ID: 26140302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.